You just read:

MeRes100 BRS - the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold - Shows Consistent Long-term Positive Safety With Consistent Low MACE rates and Zero Scaffold Stent Thrombosis for Patients With Coronary Artery Disease

News provided by

Meril Life Sciences

Jul 11, 2019, 13:00 ET